Cambridge, Boston and region

Prof. Emerita Nancy Hopkins speaks with Rebecca Sohn of STAT about the Boston Biotech Working Group’s goal of increasing the number of women leaders and entrepreneurs in biotech and her hopes for the future of women in biotech and the sciences. “You want people to feel that they are free to participate in all the things wherever it leads them,” says Hopkins. “So I think the goal is just that people who really want to do this [pursue biotech] don’t face any greater barrier than anybody else. That everybody has equal access and education to do as they want to.”

A group of MIT scientists has announced a new plan, called the Future Founders Initiative, aimed at addressing gender inequities in the biotech industry, reports Anissa Gardizy for The Boston Globe. “If we can’t advance discoveries at the same rate for women and men, that means there are drugs, therapies, devices, and diagnostics that are not getting to where they can actually benefit people,” says President Emerita Susan Hockfield. “If as a region we want to continue to lead the world, the best thing to do is not squander our resources.”

In an article for The Boston Globe, AgeLab Director Joseph Coughlin spotlights how the greater Boston area and New England in general have the “potential to become the Longevity Hub: a world-leading driver of innovation for aging populations.”

Lecturer Karilyn Crockett, the first chief of equity for the City of Boston, speaks with Dialynn Dwyer of Boston.com about her efforts aimed at improving equity in Boston. “A lot of what’s been going on has just been working in partnership internally with city departments and agencies, and then looking outside of the building to see — who are these other partners who are really willing to take on this big work of equity?” says Crockett. “It’s been an incredibly busy and productive time because there’s such an incredible appetite, and even hunger, for understanding what equity is … across the city.”

Nobull, a direct-to-consumer fitness brand co-founded by alumnus Marcus Wilson MBA ’04, is releasing a line of apparel designed by Boston teens, as part of an effort with Artists for Humanity to help connect under-resourced teens with opportunities in arts and design, reports Anissa Gardizy for The Boston Globe. 

Boston Business Journal reporter Catherine Carlock spotlights how MIT has submitted plans for the second phase of the Volpe redevelopment in Kendall Square. “The second phase could house a combined 1,400 residential units; 1.7 million square feet of lab, research and office space; a 20,000-square-foot community center; 3.5 acres of open space and other retail, entertainment and cultural facilities,” writes Carlock.

Writing for The Boston Globe, AgeLab Director Joseph Coughlin and  Research Associate Luke Yoquinto explore how Greater Boston could serve as an innovation hub for aging populations. “By making groundbreaking creativity and inventiveness for older adults both seen and felt, Greater Boston and New England will be able to offer the world a new vision of old age,” they write.

Boston Globe reporter Tim Logan writes about how MIT has submitted design plans for the next phase of its proposal to transform the Volpe Transportation Center into a dynamic mixed-use development, including “eight office and residential towers on the 14-acre site north of Broadway.”

Writing for Cambridge Day, Marieke Van Damme, executive director of the Cambridge Historical Society, explores the life and work of alumna Lois Lilley Howe, a member of the Class of 1890. Howe was “a trailblazer, one of the first women to graduate from the Massachusetts Institute of Technology’s architectural program, the organizer of the only all-woman architectural firm in Boston in the early 20th century and the first woman elected as a fellow of the American Institute of Architects,” writes Van Damme.

Boston Globe reporter Jon Chesto writes that MIT, Harvard, several research hospitals and life-sciences companies have selected a site for a new biologics manufacturing and innovation center. The project is aimed at expediting “discoveries for biotech treatments in university labs by allowing researchers to bypass the long waits that are common at contract manufacturers,” writesChesto. 

Boston Globe columnist Shirley Leung spotlights how the development of the Moderna Covid-19 vaccine demonstrates the success of the Massachusetts life sciences sector. “For more than half a century, the Massachusetts Institute of Technology has been the epicenter of that curiosity, with a focus on molecular biology — initially to find a cure for cancer,” writes Leung. “There have been Nobel laureates collaborating on cancer, genetics, and immunology, along with future laureates making discoveries in how RNA, a molecule that is as fundamental as DNA to cell function, can be used in medicine.”

Reporting for WBUR, Katie Lannan writes that Dalila Argaez Wendlandt SM ’93 has been confirmed to the Massachusetts Supreme Judicial Court, and will be the state’s first Latina high court justice. Lannan notes that Wendlandt “earned an MIT master's degree in engineering before embarking on a law career.”

Judge Dalila Argaez Wendlandt SM ’93 has been confirmed to the Massachusetts Supreme Judicial Court, reports Matt Stout for The Boston Globe. Gov. Charlie Baker noted that Wendlandt will bring “intellectual horsepower, kindness, and grace” to the court.

Katie Rae, CEO and managing partner of The Engine, speaks with Forbes reporter David Jeans about the second round of funding raised by The Engine and how the venture is looking to help support tough tech ideas. “These are things with often longer [investment] timeframes,” Rae says. “They’ve almost always been backed by government-led research, and now they are ready to translate into companies.”

TechCrunch reporter Danny Crichton writes that The Engine has announced a second round of funding aimed at supporting tough tech startups. Crichton notes that, “with this latest news from The Engine, it seems clear that Boston’s tough tech ecosystem will continue to have a pipeline of interesting and compelling companies.”